Key result
Concomitant TV surgery during AVR shows no mortality benefit but is linked to fewer reoperations.
Why the study?
Conflicting results regarding the effects of preoperative TR severity and concomitant TV surgery in patients undergoing AVR have complicated surgical decision-making.
Does concomitant tricuspid valve surgery improve outcomes in patients with moderate tricuspid regurgitation undergoing aortic valve replacement?
Cohort (n=2,679)
No
Does concomitant tricuspid valve surgery improve outcomes in patients with moderate tricuspid regurgitation undergoing aortic valve replacement?
Concomitant tricuspid valve surgery during aortic valve replacement in patients with moderate TR reduces TV-related reoperations and composite adverse events, though it does not significantly improve overall survival.
Answers are grounded in this paper and cite their sources.
Concomitant TV surgery may reduce reoperations in moderate TR at AVR but should not yet change practice; leaves open survival benefit in randomized trials.
BACKGROUND: Recent studies on the effects of preoperative tricuspid regurgitation (TR) severity and concomitant tricuspid valve (TV) surgery in patients undergoing aortic valve replacement (AVR) have yielded conflicting results, complicating the decision making on concomitant TV surgery in AVR. OBJECTIVES: The purpose of this study was to investigate the impact of preoperative TR severity on outcomes of AVR and to assess the impact of concomitant TV surgery. METHODS: Patients who underwent AVR from 2000 to 2022 were included. The primary outcome was all-cause mortality, and the secondary outcome was a composite of mortality, TV-related reoperation, stroke, and heart failure. For patients with moderate TR, the impact of TV surgery was analyzed using the inverse probability of treatment weighting to address for selection bias. RESULTS: A total of 2,679 consecutive patients (median 7.22 years, Q1-Q3: 4.21-11.83 years) constituted the study cohort. At baseline, TR severity was none-to-trivial, mild, moderate, and severe in 1,688 (63.0%), 731 (27.3%), 215 (8.0%), and 45 (1.7%) patients, respectively. Clinical outcomes demonstrated significant disparities depending on baseline TR severity (P for trend < 0.001). After adjusting for potential covariates, TV surgery did not affect overall survival among patients with moderate TR (HR: 0.57; 95% CI: 0.21-1.50). However, the TV surgery group exhibited a favorable composite outcome and lower TV-related reoperation rate (HR: 0.37; 95% CI: 0.15-0.92, and subdistribution HR: 0.07; 95% CI: 0.01-0.63, respectively). CONCLUSIONS: In patients who underwent AVR, baseline TR severity correlated with unfavorable clinical outcomes. Concomitant TV surgery reduced the rate of TV-related reoperations, but not mortality, among patients with moderate TR.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2024) conducted a cohort in Aortic valve disease with tricuspid regurgitation (n=2,679). Concomitant tricuspid valve (TV) surgery vs. No TV surgery was evaluated on All-cause mortality (in patients with moderate TR) (HR 0.57, 95% CI 0.21-1.50, p=0.254). Concomitant tricuspid valve surgery did not reduce all-cause mortality but reduced the rate of TV-related reoperations among patients with moderate tricuspid regurgitation undergoing aortic valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: